Hepatocellular carcinoma in the non-cirrhotic liver-Reference-Cited by-同舟云学术

Hepatocellular carcinoma in the non-cirrhotic liver

Published:2021-11-23 Issue: Volume: Page:1-14
ISSN:1386-0291
Container-title:Clinical Hemorheology and Microcirculation
language:
Short-container-title:CH

Author:

Yi Dong¹,Wen-Ping Wang¹,Lee Won Jae²,Meloni Maria Franca³,Clevert Dirk-Andre⁴,Cristina Chammas Maria⁵,Tannapfel Andrea⁶,Forgione Antonella⁷,Dietrich Christoph Frank⁸

Affiliation:

1. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China

2. Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Department of HealthScience and Technology and Medical Device Management and Research, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea

3. Radiology Department of Interventional Ultrasound Casa di Cura Igea, Milano, Italy Department of Radiology, University of Wisconsin, Madison, WI, USA

4. Department of Radiology, Interdisciplinary Ultrasound-Center, University ofMunich-Grosshadern Campus, Munich, Germany

5. Institute of Radiology, Hospital dasClínicas, School of Medicine, University of São Paulo, São Paulo, Brazil

6. Institut fürPathologie, Ruhr-Universität, Bochum, Germany

7. Division of Internal Medicine, Hepatobiliary andImmunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria diBologna, Bologna, Italy

8. Department AllgemeineInnere Medizin (DAIM), Kliniken Beau Site, Salem und Permanence, Hirslanden, Bern, Switzerland

Abstract

Liver cirrhosis is an established high-risk factor for HCC and the majority of patients diagnosed with HCC have cirrhosis. However, HCC also arises in non-cirrhotic livers in approximately 20 %of all cases. HCC in non-cirrhotic patients is often clinically silent and surveillance is usually not recommended. HCC is often diagnosed at an advanced stage in these patients. Current information about HCC in patients with non-cirrhotic liver is limited. Here we review the current knowledge on epidemiology, clinical features and imaging features of those patiens.

Publisher

IOS Press

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Hematology,Physiology

Reference62 articles.

1. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern;Dhamija;Indian J Med Res,2019

2. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates;Younossi;Clin Gastroenterol Hepatol,2019

3. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors;Fattovich;Gastroenterology,2004

4. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

5. Primary malignant tumours in the non-cirrhotic liver;Lee;Eur J Radiol,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Performance of Modified Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Patients Without Risk Factors for Hepatocellular Carcinoma: Comparison With World Federation for Ultrasound in Medicine and Biology Guideline;Ultrasound in Medicine & Biology;2024-02

2. Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions;Radiology;2024-01-01

3. Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesion – infectious parasitic, fungus;Medical Ultrasonography;2023-12-27

4. Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesions – infectious (bacterial);Medical Ultrasonography;2023-09-29

5. Peri-interventional LiMAx test for liver ablation – A feasibility study;Clinical Hemorheology and Microcirculation;2023-08-25